AAPS eChalk talk: FDA Modernization Act – What Does it Mean for Pharmaceutical Scientists? 网络研讨会点播 AAPS eChalk talk: FDA Modernization Act — 对制药科学家意味着什么? 历史上,FDA 要求药物发现与开发项目必须包含动物试验。With the…Certara2023 年 7 月 12 日
Introduction to compound summaries and overview of the Simcyp™ compound library Brochure Introduction to compound summaries and overview of the Simcyp™ compound library Certara2023 年 7 月 11 日
Understanding the Impact of FDA Modernization Act 2.0 on Drug Development White Paper 了解 FDA 现代化法案 2.0 对药物开发的影响 Learn how the FDA Modernization Act 2.0 will change the drug development landscape by allowing…Certara2023 年 7 月 6 日
How QSP brings insights and accelerates bispecific antibody drug development On-Demand Webinar How QSP brings insights and accelerates bispecific antibody drug development Wednesday, August 9th 2023 More than 50 bispecific antibodies are in oncology clinical development with…Certara2023 年 6 月 29 日
Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease On-Demand Webinar Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease Meet the Quantitative Systems Pharmacology (QSP) experts and view applications in Inflammatory Bowel Disease (IBD)…Certara2023 年 6 月 29 日
Project Optimus: Transforming oncology drug development On-Demand Webinar Project Optimus: Transforming oncology drug development Certara2023 年 6 月 29 日
QSP Fact Sheet: Pioneering the Field of Quantitative Systems Pharmacology Fact Sheet QSP Fact Sheet: Pioneering the Field of Quantitative Systems Pharmacology Certara2023 年 6 月 28 日
Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Publication Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…Certara2023 年 6 月 28 日
The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example Poster The Usefulness of Combining Clinical Therapeutic Drug Monitoring Data with Bottom-up System Data to Understand the Effect of Renal Impairment on the Non-renal Clearance of Drugs: Tacrolimus as a Drug Example Certara2023 年 6 月 28 日
Applying Technology to Expedite Regulatory Writing On-Demand Webinar 应用技术加快法规撰写 Many medical writing capabilities and approaches have matured over the past several years opening the…Certara2023 年 6 月 25 日